IDH1 and central nervous system cancer: To our knowledge, our study is the first report showing two co-existing IDH1 mutations detected in tissue in a patient with a glioma, and it is also the first to detect the delayed emergence of an IDH1 mutation in plasma that was sub-clonally detected in tissue 7 years earlier.